Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Seher

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
British Journal of Pharmacology|November 4, 2014
MLN4924 sensitizes monocytes and maturing dendritic cells for TNF-dependent and -independent necroptosisMohamed El-Mesery, Axel Seher, Thorsten Stühmer, et al.
The EMBO Journal|February 21, 2009
Crystal structure analysis reveals a spring-loaded latch as molecular mechanism for GDF-5-type I receptor specificityAlexander Kotzsch, Joachim Nickel, Axel Seher, et al.
The FEBS Journal|December 12, 2007
Type I receptor binding of bone morphogenetic protein 6 is dependent on N-glycosylation of the ligandStefan Saremba, Joachim Nickel, Axel Seher, et al.
BMC Biology|September 9, 2009
Receptor oligomerization and beyond: a case study in bone morphogenetic proteinsKai Heinecke, Axel Seher, Werner Schmitz, et al.
Frontiers in Immunology|March 7, 2014
TNF Receptor-Associated Factor 1 is a Major Target of Soluble TWEAKJosé Antonio Carmona Arana, Axel Seher, Manfred Neumann, et al.
Biotechnology and Applied Biochemistry|August 7, 2020
Repurposing of quinoline alkaloids identifies their ability to enhance doxorubicin-induced sub-G0/G1 phase cell cycle arrest and apoptosis in cervical and hepatocellular carcinoma cellsMohamed El-Mesery, Axel Seher, Mohamed El-Shafey, et al.
The Journal of Biological Chemistry|March 28, 2013
Fibroblast growth factor inducible (Fn14)-specific antibodies concomitantly display signaling pathway-specific agonistic and antagonistic activitySteffen Salzmann, Axel Seher, Johannes Trebing, et al.
The Journal of Biological Chemistry|November 15, 2011
Studies of binding of tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) to fibroblast growth factor inducible 14 (Fn14)Andrea Fick, Isabell Lang, Viktoria Schäfer, et al.
BMC Structural Biology|February 14, 2007
A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptorDionys Weber, Alexander Kotzsch, Joachim Nickel, et al.
International Journal of Molecular Sciences|April 3, 2021
Metabolic Fingerprinting of Murine L929 Fibroblasts as a Cell-Based Tumour Suppressor Model System for Methionine RestrictionWerner Schmitz, Corinna Koderer, Mohamed El-Mesery, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
British Journal of Pharmacology|November 4, 2014
MLN4924 sensitizes monocytes and maturing dendritic cells for TNF-dependent and -independent necroptosisMohamed El-Mesery, Axel Seher, Thorsten Stühmer, et al.
The EMBO Journal|February 21, 2009
Crystal structure analysis reveals a spring-loaded latch as molecular mechanism for GDF-5-type I receptor specificityAlexander Kotzsch, Joachim Nickel, Axel Seher, et al.
The FEBS Journal|December 12, 2007
Type I receptor binding of bone morphogenetic protein 6 is dependent on N-glycosylation of the ligandStefan Saremba, Joachim Nickel, Axel Seher, et al.
BMC Biology|September 9, 2009
Receptor oligomerization and beyond: a case study in bone morphogenetic proteinsKai Heinecke, Axel Seher, Werner Schmitz, et al.
Frontiers in Immunology|March 7, 2014
TNF Receptor-Associated Factor 1 is a Major Target of Soluble TWEAKJosé Antonio Carmona Arana, Axel Seher, Manfred Neumann, et al.
Biotechnology and Applied Biochemistry|August 7, 2020
Repurposing of quinoline alkaloids identifies their ability to enhance doxorubicin-induced sub-G0/G1 phase cell cycle arrest and apoptosis in cervical and hepatocellular carcinoma cellsMohamed El-Mesery, Axel Seher, Mohamed El-Shafey, et al.
The Journal of Biological Chemistry|March 28, 2013
Fibroblast growth factor inducible (Fn14)-specific antibodies concomitantly display signaling pathway-specific agonistic and antagonistic activitySteffen Salzmann, Axel Seher, Johannes Trebing, et al.
The Journal of Biological Chemistry|November 15, 2011
Studies of binding of tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) to fibroblast growth factor inducible 14 (Fn14)Andrea Fick, Isabell Lang, Viktoria Schäfer, et al.
BMC Structural Biology|February 14, 2007
A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptorDionys Weber, Alexander Kotzsch, Joachim Nickel, et al.
International Journal of Molecular Sciences|April 3, 2021
Metabolic Fingerprinting of Murine L929 Fibroblasts as a Cell-Based Tumour Suppressor Model System for Methionine RestrictionWerner Schmitz, Corinna Koderer, Mohamed El-Mesery, et al.
Pageof 4